Nitric Oxide and Peroxynitrite in Health and Disease

Physiological Reviews - Tập 87 Số 1 - Trang 315-424 - 2007
Pál Pacher1, Joseph S. Beckman2,3,4,5, Lucas Liaudet2,3,4,5
1Section on Oxidative Stress Tissue Injury, Laboratory of Physiologic Studies, National Institutes of Health, National Institute of Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
2Linus Pauling Institute, Department of Biochemistry and Biophysics, 2011 Agricultural and Life Sciences, Oregon State University, Corvallis, Oregon; and Department of Intensive Care Medicine,
3National Institutes of Health, NIAAA, Laboratory of Physiological Studies, 5625 Fishers Lane MSC 9413, Room 2N-17, Bethesda, MD 20892-9413
4Section on Oxidative Stress Tissue Injury, Laboratory of Physiologic Studies, National Institutes of Health, National Institute of Alcohol Abuse and Alcoholism, Bethesda, Maryland;
5University Hospital, Lausanne, Switzerland

Tóm tắt

The discovery that mammalian cells have the ability to synthesize the free radical nitric oxide (NO) has stimulated an extraordinary impetus for scientific research in all the fields of biology and medicine. Since its early description as an endothelial-derived relaxing factor, NO has emerged as a fundamental signaling device regulating virtually every critical cellular function, as well as a potent mediator of cellular damage in a wide range of conditions. Recent evidence indicates that most of the cytotoxicity attributed to NO is rather due to peroxynitrite, produced from the diffusion-controlled reaction between NO and another free radical, the superoxide anion. Peroxynitrite interacts with lipids, DNA, and proteins via direct oxidative reactions or via indirect, radical-mediated mechanisms. These reactions trigger cellular responses ranging from subtle modulations of cell signaling to overwhelming oxidative injury, committing cells to necrosis or apoptosis. In vivo, peroxynitrite generation represents a crucial pathogenic mechanism in conditions such as stroke, myocardial infarction, chronic heart failure, diabetes, circulatory shock, chronic inflammatory diseases, cancer, and neurodegenerative disorders. Hence, novel pharmacological strategies aimed at removing peroxynitrite might represent powerful therapeutic tools in the future. Evidence supporting these novel roles of NO and peroxynitrite is presented in detail in this review.

Từ khóa


Tài liệu tham khảo

Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, Endres M.Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.Int J Mol Med7: 255–260, 2001.

10.1161/01.STR.26.8.1478

10.1016/0304-3940(95)12039-7

10.1080/01616412.1997.11740784

Abou-Mohamed G, Johnson JA, Jin L, El-Remessy AB, Do K, Kaesemeyer WH, Caldwell RB, Caldwell RW.Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin.J Pharmacol Exp Ther308: 289–299, 2004.

10.1089/neu.2005.22.189

10.1152/ajpheart.01047.2002

10.1161/01.STR.0000163111.05825.0b

Ahn B, Ohshima H.Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting NO production.Cancer Res61: 8357–8360, 2001.

10.1074/jbc.274.36.25821

10.1046/j.1525-1373.2000.22519.x

10.1054/plef.2001.0304

10.1096/fj.02-0130fje

10.1038/sj.bjp.0703280

10.1016/j.freeradbiomed.2004.06.006

10.1007/s00726-003-0018-8

10.1016/j.freeradbiomed.2004.06.034

Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC.Frequent NO synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.Cancer Res58: 334–341, 1998.

10.1038/3957

10.1038/nrn1434

10.1016/j.psc.2004.10.001

10.1042/bj20031466

10.4049/jimmunol.170.4.2113

10.1038/415240a

10.1152/ajpheart.1989.256.5.H1440

Anversa P, Puntillo E, Olivetti G, Sonnenblick EH, Capasso JM.Load dependence of myocardial growth during maturation and aging.G Ital Cardiol19: 330–342, 1989.

10.1002/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO;2-5

10.1073/pnas.95.13.7659

10.1002/bies.20370

10.1161/01.RES.85.9.829

10.1016/S0014-5793(99)00073-3

10.1074/jbc.C200170200

10.2174/1567205043332162

10.1016/S0891-5849(02)00786-4

10.1073/pnas.221269198

10.1016/S0009-9120(00)00199-5

10.1016/S0008-6363(00)00091-2

10.1161/01.CIR.99.14.1885

10.1096/fj.02-0530fje

10.1016/j.archger.2003.09.006

10.1073/pnas.92.26.12041

10.1161/hq0102.101127

10.1016/j.abb.2003.08.025

Bai P, Mabley JG, Liaudet L, Virag L, Szabo C, Pacher P.Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.Oncol Rep11: 505–508, 2004.

10.1016/j.yjmcc.2004.11.004

10.1124/jpet.103.052506

10.1007/s003950200050

10.1136/heart.87.1.77

10.1161/01.ATV.19.3.646

10.1073/pnas.0402587101

10.1016/j.cell.2005.02.001

10.1074/jbc.M112451200

10.1056/NEJMoa061088

Banan A, Fields JZ, Decker H, Zhang Y, Keshavarzian A.Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction.J Pharmacol Exp Ther294: 997–1008, 2000.

10.1152/ajpgi.2001.280.6.G1234

Banham HAL, Haldane JS, Savage T.The presence post mortem of nitric-oxide-haemoglobin.Br Med J Aug1: 187–189, 1925.

10.1016/S0014-5793(01)02511-X

10.1016/j.brainresrev.2004.05.003

Barber SC, Mead RJ, Shaw PJ.Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.Biochim Biophys Acta.In press.

10.1159/000111432

10.1016/S0140-6736(04)15650-X

10.1038/nrd1330

10.1089/ars.2006.8.639

10.1021/bi060363x

10.1046/j.1523-1755.2001.0600031083.x

10.1006/phrs.2001.0893

10.1016/S0749-0704(03)00014-9

10.1002/ana.410440716

10.1002/ana.410420416

10.1161/01.CIR.0000162506.61443.15

10.1038/345027b0

10.1021/tx9501445

10.1111/j.1749-6632.1994.tb21791.x

Beckman JS.The physiological and pathological chemistry of nitric oxide. In:Nitric Oxide: Principles and Actions, edited by Lancaster JR. Orlando, FL: Academic, 1996, p. 1–82.

10.1073/pnas.87.4.1620

10.1038/364584a0

10.1016/S0166-2236(01)00004-2

10.1152/ajpcell.1996.271.5.C1424

Beckman JS, Tsai JHM.Reactions and diffusion of nitric oxide and peroxynitrite.Biochemist16: 8–10, 1994.

10.1515/bchm3.1994.375.2.81

10.1046/j.1365-201x.2000.00745.x

10.1016/j.jvs.2005.11.021

10.1152/ajpheart.1998.275.2.H501

10.1016/S0014-2999(98)00791-2

10.1039/j19700003179

10.2307/3576299

10.2143/AC.58.2.2005264

10.1161/01.CIR.0000092948.04444.C7

10.1073/pnas.93.5.1776

10.1073/pnas.95.6.2784

10.1172/JCI24761

10.1016/S0006-8993(03)03362-6

10.1080/10715760310001612568

10.1016/j.brainres.2005.01.096

10.1161/01.HYP.37.2.781

10.1002/jmv.1033

10.1089/ars.2005.7.900

10.1042/BST0321040

10.1136/ard.51.1.8

10.1016/S0003-4975(02)03953-X

Bidmon HJ, Wu J, Buchkremer-Ratzmann I, Mayer B, Witte OW, Zilles K.Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions.Neuroscience82: 377–395, 1998.

10.4049/jimmunol.171.2.528

10.1074/jbc.M105564200

10.1021/ic00216a003

10.1016/S0952-7915(99)00032-1

10.1021/bi0482250

10.1096/fasebj.13.12.1637

10.1021/ja00095a062

10.1210/endo.134.2.7507826

10.1016/S0005-2728(99)00030-4

10.1046/j.1471-4159.1995.64051965.x

10.1161/01.RES.65.3.607

10.1152/physrev.1999.79.2.609

10.1152/japplphysiol.01026.2003

10.1073/pnas.92.16.7162

10.1016/j.it.2004.03.008

10.1016/j.cardiores.2005.03.025

10.1016/S0925-4439(98)00082-9

10.1161/01.HYP.30.4.948

10.1016/S0896-6273(04)00015-7

10.1172/JCI26274

10.1074/jbc.274.33.22932

10.1016/0165-5728(95)00061-6

10.1097/01.CCM.0000050074.82486.B2

10.1161/01.HYP.30.4.934

10.1016/0306-4522(95)00349-N

10.1016/S0891-5849(02)01009-2

10.1016/S0003-4975(99)01033-4

Brahn E, Banquerigo ML, Firestein GS, Boyle DL, Salzman AL, Szabo C.Collagen induced arthritis: reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action.J Rheumatol25: 1785–1793, 1998.

Braughler JM, Mittal CK, Murad F.Effects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase.J Biol Chem254: 12450–12454, 1979.

10.1161/01.CIR.66.6.1146

10.1016/S0140-6736(02)09459-X

10.1038/347768a0

10.1073/pnas.86.22.9030

10.1073/pnas.87.2.682

10.1074/jbc.M112400200

Brito C, Naviliat M, Tiscornia AC, Vuillier F, Gualco G, Dighiero G, Radi R, Cayota AM.Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death.J Immunol162: 3356–3366, 1999.

10.1161/01.RES.0000111802.09964.EF

10.1111/j.1600-0404.2004.00207.x

10.1016/j.mito.2003.10.001

10.1016/S0014-5793(99)00217-3

10.1152/ajpheart.00742.2003

10.1016/S0005-2728(99)00025-0

10.1016/S0005-2728(00)00238-3

10.1385/MN:27:3:325

10.1016/j.bbabio.2004.03.016

10.1042/bss0660017

10.1080/15216540152845993

10.1126/science.2903551

10.1038/414813a

10.1073/pnas.94.14.7606

10.1146/annurev.neuro.27.070203.144244

10.1016/S0891-5849(00)00512-8

10.1002/jnr.490360510

10.1038/35025109

10.1126/science.1067798

10.1515/BC.2003.026

10.1074/jbc.M000181200

10.1517/14728222.10.3.445

10.1016/S0027-5107(99)00006-8

10.1016/S0304-4165(98)00065-8

10.1111/j.1750-3639.2004.tb00087.x

10.2174/0929867013373048

Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM.Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite.Lab Invest75: 77–85, 1996.

10.2337/diabetes.48.9.1856

10.1161/01.RES.87.10.840

10.1016/j.yjmcc.2004.04.012

10.1002/jnr.10408

10.1210/edrv.22.1.0417

10.5414/CNP58103

10.1152/ajpheart.1990.259.4.H1086

10.1161/01.CIR.97.9.851

10.1016/S0361-9230(03)00179-5

10.2174/0929867043364090

Caselli A, Camici G, Manao G, Moneti G, Pazzagli L, Cappugi G, Ramponi G.Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase.J Biol Chem269: 24878–24882, 1994.

10.1074/jbc.M413111200

10.1006/abbi.1996.0178

10.1074/jbc.M909978199

10.1002/jnr.10107

10.1046/j.1471-4159.2003.01786.x

10.1161/01.STR.31.4.852

Castro L, Rodriguez M, Radi R.Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide.J Biol Chem269: 29409–29415, 1994.

10.1161/01.ATV.14.5.753

10.2337/diacare.26.5.1589

Ceriello A.Nitrotyrosine: new findings as a marker of postprandial oxidative stress.Int J Clin Pract Suppl51–58, 2002.

10.1007/s001250100529

10.2337/diacare.28.3.632

10.2337/diacare.25.8.1439

10.2337/diabetes.51.4.1076

10.1161/01.CIR.0000027569.76671.A8

10.1016/S0014-5793(03)00675-6

10.1161/hh1501.094115

10.1073/pnas.96.19.10824

10.1007/s000180050353

10.1021/bi0477889

10.1152/japplphysiol.00469.2004

10.1046/j.1365-2249.1997.d01-1017.x

10.1038/35065000

10.1074/jbc.M204930200

10.1046/j.1523-1755.2003.00802.x

10.1016/S0008-6363(03)00431-0

10.1097/00003246-199910000-00030

10.1161/01.ATV.0000040223.74255.5A

10.1152/ajprenal.00352.2003

10.1038/nm849

10.1038/77528

10.2174/1566524033479582

10.1161/01.CIR.0000021120.90970.B9

10.2337/diabetes.52.9.2363

10.1016/S0008-6363(98)00317-4

10.1006/abbi.1997.0496

10.1006/jmcc.2000.1203

10.1016/j.bbrc.2005.03.034

10.1016/j.phrs.2005.02.018

10.1084/jem.176.2.599

10.1007/BF02977347

10.1016/0891-0618(96)00137-8

10.1016/0022-510X(96)00090-1

Chung KK, Dawson TM, Dawson VL.Nitric oxide,S-nitrosylation and neurodegeneration.Cell Mol Biol51: 247–254, 2005.

10.1016/0014-5793(94)00424-2

10.1189/jlb.0802401

10.1006/abbi.2001.2540

Cobbs CS, Whisenhunt TR, Wesemann DR, Harkins LE, Van Meir EG, Samanta M.Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells.Cancer Res63: 8670–8673, 2003.

10.1021/ja982887t

10.1093/brain/awh492

10.1016/S0140-6736(02)08220-X

10.1016/0014-2999(94)00672-T

10.1152/ajpcell.00295.2001

10.1172/JCI115937

10.1038/sj.bjp.0704216

10.2337/diabetes.50.8.1927

10.1080/1071576021000028442

10.1073/pnas.90.5.1731

10.1172/JCI116129

10.1016/0300-483X(88)90088-1

10.1161/01.CIR.0000051367.92927.07

10.1161/01.CIR.96.1.25

10.1038/nature01322

10.1124/jpet.105.088898

10.1016/S0008-6363(99)00148-0

10.1016/S0165-5728(98)00078-2

10.1172/JCI117282

10.1164/ajrccm.161.5.9907043

10.1006/meth.1995.1017

10.1021/bi00011a008

Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JS.Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.J Neurochem69: 1936–1944, 1997.

10.1046/j.1471-4159.1997.69051945.x

10.2174/1570161054368616

10.1161/01.RES.0000020401.61826.EA

10.1096/fj.02-1049fje

10.1152/physiolgenomics.00136.2003

10.1006/bbrc.2001.5308

10.1016/0303-7207(94)90093-0

10.1016/j.phrs.2005.02.016

10.1159/000014582

10.1016/S0014-2999(02)02338-5

10.1097/00024382-199902000-00012

10.1097/00003246-199908000-00021

10.1038/sj.bjp.0702826

10.1034/j.1600-079x.2000.280108.x

10.1016/S0006-2952(99)00067-2

10.1016/S0014-2999(99)00200-9

10.1016/S0008-6363(00)00018-3

10.1038/sj.bjp.0703421

Cuzzocrea S, Mazzon E, Di Paola R, Esposito E, Macarthur H, Matuschak GM, Salvemini D.A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin induced shock.J Pharmacol Exp Ther. In press.

Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi AP.Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.Shock16: 51–58, 2001.

10.1038/sj.bjp.0703775

10.1016/S0014-2999(01)01427-3

10.1096/fj.03-0428com

10.1097/00003246-200101000-00022

10.1097/00024382-200014020-00013

10.1096/fasebj.14.9.1061

Cuzzocrea S, Riley DP, Caputi AP, Salvemini D.Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.Pharmacol Rev53: 135–159, 2001.

10.1016/S0024-3205(98)00334-8

10.1016/S0024-3205(98)00350-6

10.1111/j.1600-079X.1998.tb00382.x

10.1038/sj.bjp.0701234

10.1038/sj.bjp.0701612

10.2174/1570161043385538

10.1002/ppul.10413

Daiber A, Herold S, Schoneich C, Namgaladze D, Peterson JA, Ullrich V.Nitration and inactivation of cytochrome P450BM-3 by peroxynitrite. Stopped-flow measurements prove ferryl intermediates.Eur J Biochem267: 6729–6739, 2000.

Daiber A, Mulsch A, Hink U, Mollnau H, Warnholtz A, Oelze M, Munzel T.The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.Am J Cardiol96: 25i–36i, 2005.

10.1016/S0162-0134(00)00110-0

10.1074/jbc.M311469200

10.1016/S0140-6736(04)16048-0

10.3109/10715769209061085

10.1006/excr.2001.5263

Davignon J, Ganz P.Role of endothelial dysfunction in atherosclerosis.Circulation109SupplIII: III-27–III-32, 2004.

10.1161/CIRCULATIONAHA.105.553206

10.1016/S0092-8674(00)00116-1

10.1073/pnas.88.17.7797

10.1126/science.1087753

10.1023/B:JOBB.0000041755.22613.8d

10.1073/pnas.88.14.6368

10.1073/pnas.94.25.13997

10.1016/S0197-4580(99)00108-6

10.1111/j.1749-6632.2000.tb06351.x

10.1046/j.1600-079X.2003.00111.x

10.1016/0968-0004(94)90280-1

10.1016/S0006-8993(00)02506-3

10.1016/S0006-8993(01)03000-1

10.1016/S0006-8993(00)02640-8

10.1194/jlr.M500384-JLR200

10.2353/ajpath.2006.050090

Deguchi T, Yoshioka M.l-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells.J Biol Chem257: 10147–10151, 1982.

10.1016/S1074-7613(02)00423-5

10.1016/0014-5793(93)80673-I

10.1210/endo.138.6.5204

10.1016/0014-5793(96)00977-5

10.1006/abbi.1996.0363

10.1016/j.tox.2004.11.023

10.1073/pnas.95.7.3566

10.1016/S0008-6363(98)00304-6

Dhar A, Brindley JM, Stark C, Citro ML, Keefer LK, Colburn NH.Nitric oxide does not mediate but inhibits transformation and tumor phenotype.Mol Cancer Ther2: 1285–1293, 2003.

Dhar A, Kaundal RK, Sharma SS.Neuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils.Pharmacol Res.In press.

10.1016/j.ejphar.2004.06.037

10.1046/j.1471-4159.2002.00980.x

Di Stasi AM, Mallozzi C, Macchia G, Petrucci TC, Minetti M.Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins.J Neurochem73: 727–735, 1999.

10.1161/01.ATV.0000189159.96900.d9

10.1016/S0891-5849(99)00184-7

10.1002/(SICI)1096-9896(199812)186:4<416::AID-PATH201>3.0.CO;2-U

10.1046/j.1365-2362.2001.00802.x

Dimmeler S, Lottspeich F, Brüne B.Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase.J Biol Chem267: 16771–16774, 1992.

10.1111/j.1349-7006.2005.00024.x

10.1016/S0895-7061(00)01248-6

10.1016/S0166-2236(99)01401-0

10.1161/01.HYP.38.3.361

10.1146/annurev.immunol.20.091301.131133

Drapier JD, Hibbs JB.Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results inl-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.J Immunol140: 2829–2838, 1988.

10.4049/jimmunol.173.10.6161

10.1016/j.freeradbiomed.2005.12.034

10.1172/JCI18127

10.1046/j.0022-3042.2001.00737.x

10.1007/s000180050357

10.1172/JCI22493

10.1016/0304-3940(91)90147-L

10.1089/152308603322110896

10.1016/S0076-6879(05)96024-2

10.1172/JCI8342

10.1073/pnas.0306734101

10.1016/j.healun.2005.02.013

Egi K, Conrad NE, Bedynek A, Ferdinandy P, Reichart B, Wildhirt SM.Improvement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase: role of peroxynitrite.J Heart Lung Transplant20: 154, 2001.

10.1080/00365510260389985

10.1016/0303-7207(96)03768-9

10.1172/JCI117188

10.1161/01.STR.31.8.1889

10.1152/ajpcell.1998.274.3.C770

10.1523/JNEUROSCI.19-14-05910.1999

10.1038/nm1097-1089

10.1038/sj.bjp.0704163

10.1006/niox.2001.0419

10.1167/iovs.02-1022

10.1242/jcs.01612

10.1016/S0002-9440(10)64332-5

10.1097/00024382-199911000-00009

10.1016/j.biopha.2003.11.004

10.1073/pnas.95.15.8880

10.1016/j.tins.2004.03.009

10.1016/S0304-3940(98)00224-9

10.1097/00004647-199711000-00002

10.1007/s00018-004-4506-0

10.1001/archneur.62.3.353

10.1006/niox.2000.0311

10.1007/s00125-003-1183-8

10.2174/1570161054368643

10.1126/science.286.5449.2498

10.1046/j.1471-4159.1995.65041543.x

10.1016/S0891-5849(99)00261-0

10.1016/S0079-6123(08)63214-8

10.1523/JNEUROSCI.18-03-00923.1998

Estevez AG, Spear N, Pelluffo H, Kamaid A, Barbeito L, Beckman JS.Examining apoptosis in cultured cells after exposure to nitric oxide and peroxynitrite. In:Nitric Oxide: Biological and Antioxidant Activities, edited by Packer L. San Diego, CA: Academic, 1998, p. 393–402.

10.1038/nrd2038

10.2174/1570161054368580

10.1038/jcbfm.1995.30

10.1016/S0306-4522(98)00492-8

10.1097/00019052-200212000-00008

10.1136/ard.51.11.1219

10.2337/diab.42.3.496

10.1038/331490a0

10.1016/S0163-7258(01)00155-3

10.1152/ajpcell.00112.2006

10.1016/j.cellsig.2004.09.009

10.1161/hc3201.092284

10.1161/01.RES.87.3.241

10.1152/ajpheart.1999.276.6.H1861

10.1038/sj.bjp.0705080

10.1074/jbc.271.37.22810

10.1002/ana.410420309

10.1590/S0100-879X2004000900005

10.1006/nbdi.1996.0006

Filep JG, Beauchamp M, Baron C, Paquette Y.Peroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood.J Immunol161: 5656–5662, 1998.

10.1186/cc1824

10.1097/00075198-200202000-00002

10.1038/35041687

10.1016/S0016-5085(98)70381-6

10.1038/nature01661

10.1067/mtc.2001.113603

Fletcher DS, Widmer WR, Luell S, Christen A, Orevillo C, Shah S, Visco D.Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats.J Pharmacol Exp Ther284: 714–721, 1998.

10.2337/diabetes.48.4.706

10.1111/j.1432-1033.1993.tb18091.x

10.1021/ac60288a034

10.2337/diabetes.51.11.3274

10.1006/abbi.1996.0538

10.1007/s004010050977

10.1007/s00228-005-0006-x

Forstermann U.NO synthases. In:Encyclopedic Reference of Molecular Pharmacology, edited by S. Offermanns and W. Rosenthal. Berlin: Springer-Verlag, 2003, p. 653–658.

10.1161/CIRCULATIONAHA.105.602532

10.1165/ajrcmb.18.3.2875

10.1161/01.CIR.0000147731.24444.4D

Fridovich I.Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase.J Biol Chem245: 4053–4057, 1970.

10.1097/00000542-199303000-00005

10.1161/01.CIR.83.6.2038

10.1161/01.RES.87.12.1123

10.1074/jbc.M106946200

10.4049/jimmunol.176.1.372

10.1161/01.RES.80.1.45

10.1016/j.bbalip.2004.03.006

10.1038/nrc1910

10.1002/jnr.490420313

10.1016/S0891-5849(96)00401-7

10.1161/01.RES.0000017632.83720.68

10.1038/288373a0

10.1227/01.NEU.0000187317.32529.06

Galkina SI, Dormeneva EV, Bachschmid M, Pushkareva MA, Sud'ina GF, Ullrich V.Endothelium-leukocyte interactions under the influence of the superoxide-nitrogen monoxide system.Med Sci Monit10: BR307–316, 2004.

10.1097/00003246-199610000-00008

10.1073/pnas.87.9.3547

10.1097/00001756-199611040-00046

10.1016/S0008-6363(02)00719-8

10.1124/jpet.301.2.543

10.1038/83241

10.1007/s00702-004-0201-4

10.1006/taap.2002.9474

Garthwaite J.Glutamate, nitric oxide and cell-cell signalling in the nervous system.Trends Neurosci14: 75–82, 1991.

10.1146/annurev.ph.57.030195.003343

10.1038/336385a0

Garthwaite J, Sotham E, Boulton CL, Nielsen EB, Schmidt K, Mayer B.Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.Biochem Pharmacol48: 184–188, 1996.

10.1006/niox.2000.0288

10.1073/pnas.211190298

10.1161/hc0202.102015

10.1074/jbc.M006972200

10.1016/j.forsciint.2004.06.027

10.1016/S0092-8674(02)00703-1

10.1126/science.290.5493.985

10.1006/jmcc.1997.0496

10.1177/135245859800400107

10.1177/135245859800400323

10.1016/S0022-510X(96)00246-8

10.1177/135245859900500506

Gloire G, Legrand-Poels S, Piette J.NF-kB activation by reactive oxygen species: fifteen years later.Biochem Pharmacol.In press.

10.1152/ajpheart.1999.277.4.H1647

10.1097/00003246-200205000-00004

10.1021/tx9802522

10.1177/153537020222701112

10.1046/j.1523-1755.2002.00233.x

10.1016/j.healun.2004.03.017

10.1097/00005072-199804000-00006

Good PF, Werner P, Hsu A, Olanow CW, Perl DP.Evidence of neuronal oxidative damage in Alzheimer's disease.Am J Pathol149: 21–28, 1996.

10.1016/S0891-5849(00)00221-5

10.1016/j.abb.2006.02.012

10.1002/hep.20662

10.1161/01.CIR.0000036743.07406.53

10.1095/biolreprod58.4.875

10.1016/0014-5793(96)00347-X

10.1152/ajplung.00295.2003

10.1016/0014-5793(93)80269-Z

10.1038/sj.bjp.0701427

Granger DN, Rutili G, McCord JM.Superoxide radicals in feline intestinal ischemia.Gastroenterology81: 22–29, 1981.

10.1159/000022861

10.1111/j.1440-1681.2005.04310.x

Graves JE, Kooy NW, Lewis SJ.l-beta,beta-Dimethylcysteine attenuates the haemodynamic responses elicited by systemic injections of peroxynitrite in anaesthetized rats.Br J Pharmacol.In press.

10.1097/01.fjc.0000181716.79580.dd

10.1152/ajpheart.1998.274.3.H1001

10.1097/01.fjc.0000181715.02452.97

10.1042/bst0220030

10.1073/pnas.78.12.7764

10.1080/10715760100300471

10.1016/j.cell.2004.07.013

10.1161/01.RES.86.5.494

10.1038/329442a0

10.1152/ajpheart.00408.2003

Groenendaal F, Lammers H, Smit D, Nikkels PG.Nitrotyrosine in brain tissue of neonates after perinatal asphyxia.Arch Dis Child Fetal Neonatal Ed.In press.

10.1152/ajpcell.1988.255.3.C297

10.1152/ajpcell.00297.2002

10.1038/320454a0

10.1152/ajpcell.00424.2002

Gu ZY, Ling YL, Xu XH, Meng AH, Li SJ.Effect of peroxynitrite on the reactivity of rabbit pulmonary arteries in vitro.Sheng Li Xue Bao55: 469–474, 2003.

Gu ZY, Ling YL, Xu XH, Zhu TN, Cong B.Endogenous peroxynitrite mediates lipopolysaccharide-induced injury in cultured pulmonary artery endothelial cells.Sheng Li Xue Bao55: 475–480, 2003.

Gugliucci A.Human plasminogen is highly susceptible to peroxynitrite inactivation.Clin Chem Lab Med41: 1064–1068, 2003.

10.1042/bj20031167

10.1074/jbc.273.34.22136

10.1016/j.pneurobio.2005.06.001

10.1152/ajpheart.00096.2003

10.1126/science.8209258

10.1161/01.STR.31.8.1974

10.1161/01.STR.0000126044.83777.f4

10.1111/j.1432-1033.2004.04193.x

10.1126/stke.2000.18.pe1

10.1016/S0021-9150(00)00524-4

10.1038/nrn1902

10.1161/01.CIR.0000012748.58444.08

10.1073/pnas.0306895101

10.1073/pnas.052712399

10.1073/pnas.96.24.13978

10.1006/niox.1998.0203

10.1038/nm0502-473

10.1146/annurev.publhealth.27.021405.102132

10.1089/089771504772695904

10.1111/j.1749-6632.1999.tb08025.x

10.1161/01.HYP.37.2.529

10.1073/pnas.171202698

10.1021/bi0509393

10.1016/j.bbapap.2003.11.009

10.1053/j.gastro.2005.11.030

10.1056/NEJMra043430

10.1074/jbc.M105730200

10.1172/JCI200524459

10.1093/geronj/11.3.298

10.1016/S0002-9149(02)03144-2

10.1046/j.1471-4159.2002.01037.x

10.1007/s00018-002-8527-2

10.1161/01.STR.21.7.1039

10.1016/S0140-6736(04)16901-8

Hausladen A, Fridovich I.Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not.J Biol Chem269: 29405–29408, 1994.

10.1016/j.cardiores.2003.09.027

10.1016/S0022-5223(03)01282-0

10.1016/S0003-4975(01)02668-6

10.1042/CS20040057

10.1023/B:JOBB.0000041765.27145.08

10.1161/01.CIR.93.6.1087

10.1161/01.RES.85.10.950

10.1016/S0306-4522(99)00350-4

10.1016/S0005-2728(98)00168-6

10.1016/j.tox.2004.11.027

10.1161/hh0102.102757

10.1046/j.1523-1755.1999.00229.x

10.1006/bbrc.1998.9581

10.1016/S1063-4584(03)00150-X

10.1523/JNEUROSCI.18-20-08126.1998

10.1016/S0027-5107(01)00111-7

10.1021/tx025595l

Herskowitz A, Choi S, Ansari AA, Wesselingh S.Cytokine mRNA expression in postischemic/reperfused myocardium.Am J Pathol146: 419–428, 1995.

10.1126/science.2432665

10.1016/S0006-291X(88)80015-9

10.1007/s004230100242

10.1161/01.HYP.30.2.252

10.1016/j.jneuroim.2004.02.005

10.1126/science.284.5415.812

10.1006/bbrc.2001.5069

10.1016/j.jacc.2003.07.009

10.1016/S0304-3940(99)00368-7

10.1016/S0304-3940(00)01784-5

10.1016/S0006-8993(99)02117-4

10.1016/S0895-7061(03)00976-2

10.2337/diabetes.51.9.2817

10.1210/jc.2002-021525

10.1161/hh2001.097796

10.1152/ajpgi.1995.268.4.G673

10.1042/bst0210358

10.1042/bj2810419

10.1016/S0005-2728(99)00027-4

10.1016/0014-5793(93)81706-6

10.1016/S0891-5849(01)00565-2

10.1080/16501970510027321

10.1006/nbdi.1998.0193

10.1161/hy1101.095331

10.1073/pnas.94.6.2528

10.1073/pnas.95.2.675

10.1073/pnas.88.7.2811

10.1056/NEJMra021333

10.1097/00024382-200204000-00007

10.1002/art.21550

Hu P, Ischiropoulos H, Beckman JS, Matalon S.Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells.Am J Physiol Lung Cell Mol Physiol266: L628–L634, 1994.

10.1161/01.RES.0000097762.64561.D2

10.1016/0092-8674(93)90615-W

10.1097/00004647-199609000-00023

10.1126/science.7522345

10.1146/annurev.biochem.69.1.373

Huber W, Menander-Huber KB, Saifer MG, Williams LD.Bioavailability of superoxide dismutase: implications for the anti-inflammatory action mechanism of orgotein.Agents Actions Suppl7: 185–195, 1980.

10.1093/ndt/gfh270

Hughes MN, Nicklin HG.The chemistry of peroxonitrites. Part II. Copper (II)-catalysed reaction between hydroxylamine and peroxonitrite in alkali.J Chem Soc1970: 925–928, 1970.

10.1016/0304-4165(70)90192-3

10.1021/tx960188t

10.3109/10715769309145868

10.1016/S0741-5214(99)70174-6

10.1158/0008-5472.CAN-04-2201

10.2307/3570395

10.1097/00019052-200102000-00014

10.1038/jcbfm.1995.6

10.1161/01.STR.27.8.1373

10.1523/JNEUROSCI.17-23-09157.1997

10.1152/ajpregu.1995.268.1.R286

10.1016/0014-2999(92)90526-A

10.1161/01.CIR.0000134595.80170.62

Ignarro LJ.Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins.Semin Hematol26: 63–76, 1989.

10.1023/A:1020150124721

Ignarro LJ, Adams JB, Horwitz PM, Wood KS.Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange.J Biol Chem261: 4997–5002, 1986.

Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ.Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.J Pharmacol Exp Ther237: 893–900, 1986.

10.2337/db06-0067

10.1016/S0891-5849(02)01180-2

10.1152/ajpheart.1990.259.3.H925

10.1111/j.1749-6632.1996.tb39065.x

10.1160/TH05-08-0591

10.1016/0735-1097(90)92845-S

10.1097/00003246-200206000-00021

10.1016/S0006-291X(03)00814-3

10.1006/abbi.1998.0755

10.1152/ajplung.1995.269.2.L158

10.1172/JCI200317638

Ischiropoulos H, Chen J, Tsai JHM, Martin JC, Smith CD, Beckman JS.Peroxynitrite (ONOO−) reacts with superoxide dismutase to give the reactive nitronium ion (Abstract).Free Rad Biol Med9: 131, 1990.

10.1016/S0076-6879(99)01100-3

10.1016/0003-9861(92)90433-W

10.1016/0003-9861(92)90431-U

10.1016/S0076-6879(99)01104-0

10.1016/0891-5849(96)02060-6

Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, Pollock JS, Carmines PK.Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus.J Am Soc Nephrol12: 1630–1639, 2001.

10.1161/01.CIR.95.2.489

10.1016/j.bbrc.2004.01.046

10.1161/01.RES.0000063423.94645.8A

10.1002/ijc.11268

Jaeschke H.Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol.J Pharmacol Exp Ther255: 935–941, 1990.

10.1152/ajpgi.00342.2002

10.1093/toxsci/kfi336

10.1097/00003246-200205000-00019

10.1021/jm0502891

Jaiswal M, LaRusso NF, Nishioka N, Nakabeppu Y, Gores GJ.Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide.Cancer Res61: 6388–6393, 2001.

10.1053/gast.2001.20875

10.1016/j.biochi.2005.06.016

10.1164/rccm.2108138

10.1097/01.shk.0000054374.88889.37

10.1016/j.freeradbiomed.2005.06.018

10.1073/pnas.92.10.4392

10.1002/ana.10483

10.1074/jbc.M509480200

10.1152/ajpgi.2000.279.3.G641

Jin L, Abou-Mohamed G, Caldwell RB, Caldwell RW.Endothelial cell dysfunction in a model of oxidative stress.Med Sci Monit7: 585–591, 2001.

10.1016/j.yjmcc.2005.09.011

10.1152/ajpheart.00245.2004

10.1006/abbi.2000.1728

10.1073/pnas.152149699

10.4049/jimmunol.176.2.1195

10.1073/pnas.202296999

10.1161/01.RES.82.5.576

10.1016/j.lfs.2005.06.029

10.1002/jnr.10649

10.1006/niox.2001.0389

10.2337/diabetes.50.6.1414

10.1016/0306-4522(93)90107-Q

10.1097/00007890-200112270-00003

10.1042/bj3460641

10.1016/0003-9861(86)90380-2

10.2337/diab.44.7.733

10.1016/S1089-8603(02)00117-9

10.1016/S0024-3205(02)01564-3

10.1152/ajpheart.01030.2003

10.1074/jbc.M501773200

10.1097/01.hjh.0000173520.13976.7d

10.1172/JCI24015

10.1093/jb/mvi163

Kasina S, Wasia R, Fasim A, Radhika KV, Singh SS.Phorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration.Nitric Oxide14: 65–71, 2006.

10.1006/bbrc.2000.3559

10.1038/nm1362

10.1016/j.injury.2004.12.037

10.1006/jmcc.2002.1539

10.1523/JNEUROSCI.18-02-00687.1998

10.1515/REVNEURO.1998.9.2.105

10.1016/S0016-5085(98)70534-7

10.1097/00019501-200409000-00007

10.1080/13510002.1997.11747120

10.1074/jbc.272.44.27652

10.1152/ajpheart.00549.2001

Khan F, Ali R.Antibodies against nitric oxide damaged polyl-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus.J Biochem Mol Biol39: 189–196, 2006.

10.1016/j.niox.2006.01.008

10.1074/jbc.M310045200

10.1161/01.RES.0000183881.11739.CB

10.1097/01.wco.0000169741.29535.cc

10.1093/gerona/61.4.332

10.1161/hs0302.103745

10.1021/ja00039a068

10.1186/1471-2210-4-26

10.1097/01.mop.0000193291.09894.6c

10.1056/NEJMoa060442

Kisley LR, Barrett BS, Bauer AK, Dwyer-Nield LD, Barthel B, Meyer AM, Thompson DC, Malkinson AM.Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.Cancer Res62: 6850–6856, 2002.

10.1016/S0014-2999(97)01246-6

10.1016/j.chembiol.2004.12.011

10.1016/0014-5793(93)80954-S

10.1172/JCI200318182

10.1042/bj3520219

Klug D, Rabani J, Fridovich I.A direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis.J Biol Chem247: 4839–4842, 1972.

10.1006/bbrc.2001.5448

10.1093/toxsci/62.2.212

10.1161/hc0702.103977

10.1021/bi051226n

10.1097/00004872-200212000-00028

10.1179/016164106X98215

10.1074/mcp.M300141-MCP200

10.1016/j.phrs.2005.02.011

10.1111/j.1460-9568.2004.03632.x

10.1038/sj.mn.7800142

10.1161/01.RES.74.3.416

Koller WC.Paraquat and Parkinson's disease.Neurology36: 1147, 1986.

10.1523/JNEUROSCI.17-11-04180.1997

10.1073/pnas.93.8.3377

10.1016/S0014-5793(98)00413-X

10.1016/0014-2999(96)00343-3

10.1016/0014-2999(96)00376-7

10.1016/S0014-2999(96)00623-1

10.1097/00003246-199705000-00017

10.1179/135100001101536517

10.1021/tx00030a017

10.1002/1531-8249(200101)49:1<139::AID-ANA28>3.0.CO;2-A

10.1152/ajpheart.2000.278.4.H1311

10.2337/diabetes.52.3.818

10.1080/10715760310001604189

10.1084/jem.194.9.1207

10.1007/BF00405081

10.1006/niox.1998.0204

10.1152/ajpgi.1993.264.1.G143

10.1523/JNEUROSCI.19-23-10289.1999

10.1074/jbc.274.42.29726

10.1016/S0006-8993(02)02307-7

10.1074/jbc.M200290200

Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto I.Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver.Hepatogastroenterology51: 1404–1407, 2004.

Kurzelewski M, Czarnowska E, Beresewicz A.Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, enhanced neutrophil adhesion in the post-ischemic guinea-pig heart.J Physiol Pharmacol56: 163–178, 2005.

10.1161/01.CIR.0000153800.09920.40

10.1074/jbc.M302227200

10.1161/01.CIR.0000048894.99865.02

10.1161/01.CIR.0000048893.62841.F7

10.1073/pnas.91.17.8137

10.1016/j.jacc.2004.01.047

10.1016/j.freeradbiomed.2003.11.026

10.1097/01.hco.0000179821.11071.79

10.1042/bj20020339

10.1161/hh0901.090299

10.1161/01.CIR.103.9.1282

10.1074/jbc.M006341200

10.1074/jbc.275.13.9369

10.1073/pnas.232308999

10.1074/jbc.M302332200

10.1097/00024382-200116050-00006

10.1152/ajpheart.00808.2002

10.1056/NEJMoa052980

10.1074/jbc.272.3.1433

10.1016/S0008-6363(96)00073-9

10.1172/JCI119212

10.1097/00024382-200304000-00009

10.1016/0896-6273(92)90130-6

10.1161/01.ATV.0000093980.46838.41

10.1016/j.freeradbiomed.2005.02.013

10.1074/jbc.M501977200

10.1016/j.freeradbiomed.2006.04.034

Lewis SJ, Hoque A, Sandock K, Robertson TP, Bates JN, Kooy NW.Differential effects of peroxynitrite on the function of arginine vasopressin V(1a) receptors and alpha(1)-adrenoceptors in vivo.Vasc Pharmacol.In press.

10.1016/j.ejphar.2005.06.027

10.1007/s00125-004-1356-0

10.2337/diabetes.53.9.2436

10.1177/153537020422900307

10.1016/S0304-3940(03)00881-4

10.1152/ajpregu.00124.2004

10.1016/j.bbrc.2006.02.046

10.1096/fasebj.13.10.1137

10.1042/bj3310599

10.1038/ng1295-376

10.1097/00075197-200203000-00010

10.1164/ajrccm.164.7.2101013

10.1128/IAI.70.1.192-198.2002

10.1097/00075198-200304000-00012

10.1097/00003246-200004001-00005

10.1073/pnas.170226797

10.1097/00024382-200014020-00010

10.1097/00019501-200304000-00004

10.1007/BF03402187

10.1128/MCB.10.5.2327

10.1021/tx020040b

10.1074/jbc.270.28.16487

10.1046/j.1523-1755.1998.00913.x

10.1023/A:1022151106019

10.3317/jraas.2003.029

10.1016/S0891-5849(03)00024-8

10.1152/physrev.1999.79.4.1431

10.1038/364626a0

10.1016/S0002-9440(10)64677-9

10.1152/ajpheart.1997.272.5.H2327

10.1152/ajpcell.2000.279.6.C1970

Liu S, Beckman JS, Ku DD.Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs.J Pharmacol Exp Ther268: 1114–1121, 1994.

10.1073/pnas.95.5.2175

10.1046/j.1440-1681.2002.03649.x

10.1161/01.RES.0000046003.14031.98

10.1097/00005373-199912000-00022

10.1097/01.TP.0000131155.81609.37

10.1161/01.CIR.0000156461.81529.D7

10.1097/00019501-199703000-00005

10.1016/j.neulet.2005.04.089

10.1091/mbc.01-05-0272

10.1046/j.1365-2990.1999.00179.x

10.1046/j.1365-2990.2000.00218.x

10.1016/S0014-5793(01)03279-3

10.1016/j.molimm.2004.04.010

10.1172/JCI118613

10.1152/ajpgi.00054.2005

10.1146/annurev.ph.52.030190.003021

10.1016/0002-9149(90)90120-P

10.1016/S0140-6736(94)90460-X

10.1161/01.ATV.18.2.157

10.1053/gast.2003.50001

10.1016/S0006-8993(01)02758-5

10.1016/S0006-8993(99)02178-2

10.1016/S0006-8993(02)03280-8

10.2337/diacare.21.10.1753

Lymar S, Wishart J.Reactivity of peroxynitrite: implications for hanford waste management and remediationEnvironmental Management Science Program Project59982, 1998.

10.1021/tx960046z

10.1021/tx00048a003

10.1021/bi960331h

10.1021/ic030104l

10.1016/j.bbrc.2004.04.193

10.1016/j.niox.2005.09.012

Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL, Barone FC.Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.J Pharmacol Exp Ther298: 879–885, 2001.

10.1016/S0008-6363(97)00179-X

Maas AI, Marmarou A, Murray GD, Steyerberg EW.Clinical trials in traumatic brain injury: current problems and future solutions.Acta Neurochir Suppl89: 113–118, 2004.

10.1007/PL00000234

10.1007/BF03402168

10.1016/j.mrfmmm.2004.01.006

10.2174/1570161054368571

10.1097/00006676-200403000-00018

10.1016/S0006-291X(03)00762-9

10.1021/tx980253u

10.1016/0092-8674(95)90085-3

10.1073/pnas.93.21.11853

10.1080/10715760100300281

10.1016/S0891-5849(01)00750-X

10.1006/abbi.2000.1799

10.1006/abbi.1999.1202

10.1016/S0925-4439(99)00107-6

10.1021/ja00720a068

10.1038/jcbfm.1995.55

10.1038/jcbfm.1993.48

10.1046/j.1432-1327.2000.01498.x

10.1016/j.freeradbiomed.2005.02.021

10.1016/S0014-5793(99)00945-X

10.1016/S0014-5793(01)02726-0

10.1096/fasebj.11.14.9409547

10.1016/S0891-5849(01)00509-3

10.1161/01.STR.0000204043.18592.0d

10.1002/1529-0131(200107)44:7<1534::AID-ART276>3.0.CO;2-#

10.1042/bj2590181

10.1073/pnas.141222598

10.1016/S0891-5849(96)00629-6

10.1172/JCI118328

10.1016/S0891-5849(99)00094-5

10.1002/jcp.10119

10.1161/01.RES.0000088351.58510.21

10.1067/mtc.2000.106835

10.1074/jbc.M106393200

10.1097/01.shk.0000174936.51903.7d

10.1161/hh2101.098443

10.1074/jbc.270.29.17355

10.1042/bj2610293

10.1084/jem.178.2.749

10.1002/1529-0131(199906)42:6<1119::AID-ANR8>3.0.CO;2-3

10.1056/NEJM198501173120305

McCord JM, Fridovich I.Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein).J Biol Chem244: 6049–6055, 1969.

10.1084/jem.184.4.1519

10.1038/nrc1647

10.1164/rccm.2203034

10.1097/01.TP.0000053400.42842.5C

10.1067/mtc.2003.97

10.1073/pnas.0405509101

10.2174/1389450053344975

10.1016/S0304-4165(98)00072-5

Merényi G, Lind J, Goldstein S, Czapski G.Mechanism and thermochemistry of peroxynitrite decomposition in water.J Phys Chem103: 3085–3091, 1999.

10.1152/ajpheart.2001.280.6.H2631

10.1152/ajpheart.00716.2001

10.1007/s003950170023

10.3233/JAD-2004-6206

10.1016/S0300-9084(83)80179-5

10.1016/0140-6736(93)90211-X

10.1007/BF01534394

Migita K.Nitric oxide in rheumatoid arthritis.Nippon Rinsho63Suppl1: 106–109, 2005.

10.1016/S0300-9084(02)00005-6

10.1016/S0008-6363(00)00307-2

10.1097/00005344-200008000-00007

10.1016/S0006-2952(03)00012-1

10.1161/01.CIR.104.2.174

10.1016/S0300-9084(03)00090-7

10.1038/sj.bjp.0704495

10.1006/bbrc.1996.0519

10.1016/0016-5085(95)90633-9

10.1096/fj.03-0013fje

10.1016/S0891-5849(02)00891-2

10.1016/0014-5793(94)00596-6

10.1161/01.RES.0000012569.55432.02

10.1111/j.1471-4159.2006.03988.x

10.1038/nrm762

10.1016/0165-6147(87)90090-3

10.1038/sj.bjp.0706458

10.1073/pnas.83.23.9164

Moncada S, Palmer RMJ, Higgs EA.Nitric oxide: physiology, pathophysiology, pharmacology.Pharmacol Rev43: 109–142, 1991.

10.1016/S0891-5849(96)00510-2

10.1093/cercor/1.3.199

10.1097/01.ta.0000174858.79847.6d

10.1161/01.RES.77.2.335

10.1007/s00702-004-0242-8

10.1196/annals.1333.062

10.1016/S0008-6363(98)00146-1

10.1006/bbrc.1997.6287

10.1016/S0022-4804(02)00065-3

10.1172/JCI24351

10.1016/j.freeradbiomed.2005.07.010

10.1016/j.ceca.2004.02.011

10.1073/pnas.91.14.6702

10.1111/j.1476-5381.1995.tb16404.x

10.1074/jbc.M509261200

10.1097/00024382-199910000-00002

10.1002/jcb.1175

10.1172/JCI0213265

10.1161/01.RES.0000095452.77140.7A

10.1523/JNEUROSCI.18-01-00205.1998

10.1002/jat.922

10.1002/1099-1263(200011/12)20:6<435::AID-JAT710>3.0.CO;2-O

10.1006/niox.2000.0285

10.1074/jbc.M305694200

10.1161/01.CIR.74.5.1124

10.1124/jpet.104.068205

10.1152/ajplung.00178.2002

10.1046/j.1471-4159.2000.0741636.x

10.1016/S0014-4800(03)00015-7

10.1016/S1053-2498(02)00556-9

10.1016/j.niox.2004.04.002

10.1161/01.HYP.0000177474.06749.98

Nakajima A, Ueda K, Takaoka M, Yoshimi Y, Matsumura Y.Opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury.J Pharmacol Exp Ther316: 1038–1046, 2006.

10.1080/003655299750024922

10.1016/S1353-8020(01)00028-1

Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ.Nitric oxide and atherosclerosis: an update.Nitric Oxide.In press.

10.1161/01.ATV.14.5.746

10.1172/JCI200318174

10.1016/0092-8674(94)90266-6

Nathan C, Xie QW.Regulation of biosynthesis of nitric oxide.J Biol Chem269: 13725–13728, 1994.

10.1016/0952-7915(91)90079-G

10.1021/jp025518z

10.1152/ajpregu.00208.2003

10.1074/jbc.M407117200

10.1152/ajplung.00391.2005

10.1016/S0006-291X(02)02060-0

10.1016/S0092-8674(03)00116-8

10.1213/01.ANE.0000116962.93953.70

10.1097/00075197-199909000-00008

10.1016/j.niox.2005.11.001

10.1046/j.1523-1755.2000.07705.x

Nohl H.Generation of superoxide radicals as byproduct of cellular respiration.Ann Biol Clin52: 199–204, 1994.

10.1172/JCI118681

10.1016/j.bbrc.2004.06.019

10.1152/ajpheart.1998.275.2.H509

10.1161/01.CIR.96.7.2317

10.1023/B:MCBI.0000049370.23457.10

10.1080/0953770021000007230

Oates JC, Gilkeson GS.The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus.Clin Immunol.In press.

10.1046/j.1365-2249.1999.00878.x

10.1089/ars.2005.7.1543

10.2337/diabetes.54.12.3435

10.2174/1570161054368634

10.2337/diabetes.53.3.711

10.1096/fj.04-1913fje

Obrosova IG, Minchenko AG, Frank RN, Seigel GM, Zsengeller Z, Pacher P, Stevens MJ, Szabo C.Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.Int J Mol Med14: 55–64, 2004.

10.2337/diabetes.54.1.234

10.1021/tx980207u

10.1007/s11883-000-0083-3

10.1016/S0891-5849(00)00461-5

10.1016/j.autrev.2004.11.011

10.1016/0278-6915(90)90173-K

10.1016/S0168-0102(02)00238-9

10.1089/ars.2005.7.1315

10.1124/jpet.102.035857

10.1074/jbc.M102417200

Oleszak EL, Zaczynska E, Bhattacharjee M, Butunoi C, Legido A, Katsetos CD.Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis.Clin Diagn Lab Immunol5: 438–445, 1998.

10.1093/emboj/18.16.4446

10.1046/j.1523-1755.2002.00123.x

10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2

10.1046/j.1471-4159.2001.00198.x

10.1152/japplphysiol.01302.2004

10.1172/JCI986

Oyanagui Y.Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats.Life Sci54: PL285–289, 1994.

10.1016/S1043-6618(02)00037-3

10.1007/BF03165803

10.1159/000046888

10.1016/S0006-2952(02)01421-1

10.1093/emboj/20.15.4107

10.1161/01.CIR.0000048192.52098.DD

10.1124/jpet.300.3.862

10.1016/S0735-1097(02)02062-4

Pacher P, Liaudet L, Mabley JG, Cziraki A, Hasko G, Szabo C.Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.Int J Mol Med17: 369–375, 2006.

10.2337/diabetes.51.2.514

10.1152/ajpheart.00405.2004

10.1038/sj.bjp.0704627

Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabo C.Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging.Int J Mol Med9: 659–664, 2002.

10.1124/pr.58.1.6

10.2174/0929867053363207

10.1016/j.tips.2005.04.003

10.1016/j.coph.2006.01.001

10.1089/ars.2005.7.1568

10.1124/jpet.104.069658

10.1016/0014-5793(94)00461-7

10.1111/j.1432-1033.1995.231_c.x

10.1073/pnas.0401723101

10.1016/S0014-5793(98)00108-2

10.1016/j.neuint.2006.04.010

10.1016/j.cardiores.2006.05.001

10.1074/jbc.M304362200

10.1074/mcp.M400195-MCP200

10.1074/jbc.M303306200

10.1038/sj.bjp.0702549

10.1016/S0076-6879(96)69038-7

Patel RP, Diczfalusy U, Dzeletovic S, Wilson MT, Darley-Usmar VM.Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, copper.J Lipid Res37: 2361–2371, 1996.

10.1016/S0005-2728(99)00028-6

10.1016/S0891-5849(00)00235-5

10.1016/0968-0004(79)90203-2

10.1023/A:1020754232359

10.1074/jbc.M109838200

10.1016/j.niox.2005.07.010

10.1074/jbc.274.50.35763

10.1111/j.1471-4159.2004.02357.x

10.1074/jbc.M406762200

10.1074/jbc.274.49.34621

10.1172/JCI11194

10.1016/j.neuroscience.2005.06.027

10.1016/S0006-8993(02)03102-5

10.1016/j.yjmcc.2005.02.020

10.1097/00004647-199802000-00011

10.1021/ja00830a026

10.1124/jpet.105.083493

10.1016/S0006-291X(88)80080-9

10.1093/carcin/bgh157

10.1016/S0008-6363(98)00033-9

10.1038/338633a0

10.1016/j.jtcvs.2004.11.052

10.1172/JCI5549

10.1002/dmrr.385

10.2174/157016105774329408

10.1136/bmj.321.7259.490

10.1517/14712598.3.1.127

10.1089/ars.2006.8.144

10.1016/S0014-2999(98)00618-9

10.1016/S0891-5849(03)00401-5

10.1152/ajplung.1995.268.5.L699

10.1046/j.1471-4159.2001.00174.x

Przedborski S, Jackson-Lewis V, Djaldetti R, Liberatore G, Vila M, Vukosavic S, Almer G.The parkinsonian toxin MPTP: action and mechanism.Restor Neurol Neurosci16: 135–142, 2000.

10.1073/pnas.93.10.4565

Pu M, Akhand AA, Kato M, Hamaguchi M, Koike T, Iwata H, Sabe H, Suzuki H, Nakashima I.Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation.Oncogene13: 2615–2622, 1996.

10.1152/ajplung.1999.277.4.L769

10.1023/A:1012331108641

10.1242/jcs.02470

10.2337/diabetes.52.11.2795

10.1016/S0021-9150(02)00197-1

10.1210/endo.137.5.8612552

10.1016/0016-5085(93)91063-N

10.1073/pnas.0307446101

10.1021/tx980096z

10.1016/0003-9861(91)90224-7

Radi R, Beckman JS, Bush KM, Freeman BA.Peroxynitrite-mediated sulfhydryl oxidation: the cytotoxic potential of superoxide and nitric oxide.J Biol Chem266: 4244–4250, 1991.

Radi R, Beckman JS, Bush KM, Freeman BA.Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.J Biol Chem266: 4244–4250, 1991.

10.1515/BC.2002.044

10.1016/S0891-5849(02)01111-5

10.1042/bj2900051

10.1016/S0891-5849(00)00373-7

10.1006/abbi.1994.1013

10.1006/bbrc.1994.1368

10.1006/bbrc.1999.1216

10.1172/JCI118623

10.1056/NEJM199201093260203

10.1016/j.bcp.2005.04.042

10.1016/S0896-6273(02)00905-4

10.1161/01.CIR.97.23.2338

10.1038/ng0596-43

Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA.Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes.J Pharmacol Exp Ther312: 509–516, 2005.

10.1074/jbc.M311997200

10.1021/bi047982v

10.1021/bi052142h

10.1016/0009-3084(87)90049-1

10.1073/pnas.0502979102

10.1016/S0021-9150(02)00010-2

10.1016/S0891-5849(01)00489-0

10.1016/j.freeradbiomed.2005.02.010

10.1161/01.HYP.0000052833.20759.64

10.1038/sj.bjp.0701595

10.1016/S0014-2999(03)01457-2

10.1016/S0008-6363(99)00184-4

Ronson RS, Thourani VH, Ma XL, Katzmark SL, Han D, Zhao ZQ, Nakamura M, Guyton RA, Vinten-Johansen J.Peroxynitrite, the breakdown product of nitric oxide, is beneficial in blood cardioplegia but injurious in crystalloid cardioplegia.Circulation100SupplII: II-384–II-391, 1999.

10.1016/j.yjmcc.2006.01.010

10.1038/362059a0

10.1016/j.bbrc.2005.03.012

10.1056/NEJM200105313442207

10.1152/ajpheart.1986.250.5.H822

Rubbo H, Batthyany C, Radi R.Nitric oxide-oxygen radicals interactions in atherosclerosis.Biol Res33: 167–175, 2000.

10.1021/tx960037q

10.1006/abbi.1994.1013

10.1016/j.tox.2004.11.019

10.1515/BC.2002.055

10.1016/j.neuint.2003.12.012

10.1016/j.expneurol.2004.01.006

10.1016/S0891-5849(02)00890-0

10.1021/bi060474w

10.1016/S0168-0102(00)00138-3

10.1016/S0168-0102(99)00019-X

10.1002/jcb.10180

Saez TE, Pehar M, Vargas M, Barbeito L, Maccioni RB.Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons.In Vivo18: 275–280, 2004.

10.1172/JCI118292

10.1097/00007890-199912150-00031

10.1006/bbrc.1995.2578

10.1016/S0006-8993(00)02095-3

10.1016/S0891-5849(02)00961-9

10.1002/1529-0131(200112)44:12<2909::AID-ART479>3.0.CO;2-#

10.1038/sj.bjp.0702604

10.1016/0014-2999(96)00140-9

10.1073/pnas.95.5.2659

10.1016/S0076-6879(96)69023-5

10.1006/abbi.1998.0772

Sanchez-Ramos JR, Hefti F, Weiner WJ.Paraquat and Parkinson's disease.Neurology37: 728, 1987.

Sandhu JK, Robertson S, Birnboim HC, Goldstein R.Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis.J Rheumatol30: 1173–1181, 2003.

Sangha O.Epidemiology of rheumatic diseases.Rheumatology39Suppl2: 3–12, 2000.

10.1002/syn.20084

10.1194/jlr.M300497-JLR200

10.1007/s00726-003-0028-6

10.1385/JMN:15:3:243

10.1093/jnen/60.9.839

10.1016/S1050-1738(96)00121-1

10.1136/gut.2005.082909

10.1016/j.niox.2005.06.005

10.1021/ar00072a005

10.1006/smim.2000.0219

10.1016/0006-2952(96)99426-5

10.1016/S0014-5793(99)00372-5

10.1016/S0092-8674(00)00114-8

10.1074/jbc.M208080200

10.1016/S0047-6374(98)00158-4

10.1016/j.tibs.2003.10.006

10.1006/bbrc.2001.5210

10.1006/bbrc.2001.6134

10.1023/A:1006852306789

10.1152/ajpheart.1997.272.3.H1212

10.1126/science.1720572

10.1164/ajrccm.164.3.2004026

10.1097/00007890-200110270-00005

10.1053/gast.2001.27994

10.1054/mehy.2000.1118

10.1016/S0304-3940(01)02160-7

10.1038/sj.jp.7211497

10.1016/0021-9150(95)05563-C

10.1126/science.1062677

10.1016/S0002-9610(03)00075-8

10.1016/S0006-8993(03)03364-X

10.1038/sj.cdd.4401831

10.1016/S0163-7258(99)00072-8

10.1016/S0921-8777(00)00016-1

10.1021/bi00387a015

10.1016/S1072-7515(98)00163-X

10.1016/S0891-5849(02)00979-6

10.1016/0306-9877(92)90175-C

10.1006/bbrc.1999.0434

10.1016/0006-8993(96)00617-8

10.1016/S0014-5793(02)03059-4

10.1016/S0304-3940(03)00558-5

10.1161/hc0102.101399

10.1016/S0165-5728(98)00194-5

10.1073/pnas.131128898

10.1128/MCB.24.15.6763-6772.2004

10.1038/sj.bjc.6600224

10.1074/jbc.271.19.11204

10.1073/pnas.200285797

10.1006/exnr.2000.7448

10.1146/annurev.pa.36.040196.000503

10.1016/S1474-4422(05)70052-1

10.1016/S0197-0186(01)00122-X

10.1016/S0016-5085(96)70055-0

Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED.Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy.J Cereb Blood Flow Metab.In press.

10.1161/01.RES.88.1.103

10.1161/01.ATV.0000044458.23905.3B

10.1016/0003-9861(92)90286-6

10.1111/j.1750-3639.1999.tb00212.x

10.1523/JNEUROSCI.17-08-02653.1997

10.1016/j.coph.2005.01.002

10.1016/S0008-6363(02)00786-1

10.1385/CT:2:2:129

10.1161/01.CIR.101.14.1722

10.1089/152308602760598954

10.1111/j.1527-5299.2002.00717.x

10.1097/00024382-200204000-00008

10.1097/01.CCM.0000206470.47721.8D

10.1161/hh2001.097797

10.1007/s001090100236

10.1146/annurev.immunol.23.021704.115707

10.1111/j.1471-4159.1991.tb03468.x

10.1042/bj2720243

10.1006/abbi.1999.1480

10.1074/jbc.M000206200

10.1006/abbi.1998.0932

Spear N, Estevez AG, Barbeito L, Beckman JS, Johnson GV.Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase.J Neurochem69: 53–59, 1997.

10.1007/s00125-002-0782-0

10.1177/135245850100700305

10.1084/jem.184.3.1173

10.1074/jbc.273.27.16694

10.1016/S0891-5849(03)00499-4

10.1089/152308603770310239

10.1016/S0092-8674(01)00495-0

10.1126/science.1281928

Stanger O, Weger M.Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.Clin Chem Lab Med41: 1444–1454, 2003.

Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH.Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis.J Rheumatol22: 1922–1928, 1995.

10.2174/1570161054368544

10.1016/S0891-5849(02)01327-8

10.1677/joe.1.06069

10.1001/jama.281.8.727

10.1084/jem.169.5.1543

10.1006/jaut.2001.0507

10.2337/diab.46.5.907

Sucu N, Unlu A, Tamer L, Aytacoglu B, Ercan B, Dikmengil M, Atik U.3-Nitrotyrosine in atherosclerotic blood vessels.Clin Chem Lab Med41: 23–25, 2003.

10.1096/fj.00-0176com

10.1152/ajpheart.00854.2003

10.1016/S0002-9440(10)64454-9

Suschek C, Fehsel K, Kroncke KD, Sommer A, Kolb-Bachofen V.Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration.Am J Pathol145: 685–695, 1994.

10.1038/17135

10.1097/01.hjh.0000226196.67052.c0

10.1016/S0006-8993(02)03145-1

10.1021/bi050276p

10.1097/00003246-200011000-00026

10.1016/S0891-5849(96)00275-4

10.1093/rheumatology/41.7.793

10.1097/00024382-199811000-00007

10.1097/00003246-199907000-00027

10.1016/S0024-3205(99)80010-1

Szabo C.Alterations in nitric oxide production in various forms of circulatory shock.New Horizons3: 2–32, 1995.

Szabo C.Multiple pathways of peroxynitrite cytotoxicity.Toxicol Lett140–141: 105–112, 2003.

10.2174/1570161054368553

10.1016/0361-9230(96)00159-1

10.1016/j.niox.2005.06.008

10.1097/00024382-199805000-00005

10.1016/j.phrs.2005.02.015

10.1172/JCI119585

10.1007/BF03402167

10.1006/niox.1997.0143

10.2119/2004-00001.Szabo

10.1016/0014-5793(95)00322-Z

10.1016/0014-5793(95)00984-H

10.1165/ajrcmb.16.2.9032115

10.1073/pnas.95.7.3867

10.1073/pnas.95.7.3867

10.1161/01.CIR.0000038365.78031.9C

10.1073/pnas.93.5.1753

10.1161/01.RES.78.6.1051

10.2174/1570161054368599

10.1016/j.cardiores.2003.09.029

10.1161/01.CIR.94.7.1665

10.1161/01.CIR.103.20.2514

10.1097/00007890-199803270-00007

10.1159/000051028

10.1042/BST0331082

10.1016/S0006-8993(02)02975-X

10.1161/01.CIR.91.7.1981

10.1006/abbi.1999.1374

Takakura K, Xiaohong W, Takeuchi K, Fukuda S.Peroxynitrite decreases dopamine's vasoconstrictive activity.Anesth Analg97: 1492–1496, 2003.

10.1097/00000542-200304000-00020

10.1007/s10620-006-3172-5

10.1097/00004647-200201000-00006

10.1097/00004647-199906000-00010

Takizawa S, Hirabayashi H, Fukuyama N, Nakazawa H, Shinohara Y.Peroxynitrite production in cerebral ischemia.Rinsho Shinkeigaku39: 1295–1297, 1999.

10.1016/0891-5849(93)90040-2

10.1046/j.1365-201X.2003.01100.x

10.1097/00024382-200116020-00013

10.1055/s-0037-1614841

10.1007/s001250051192

10.1096/fj.05-3795fje

10.1038/sj.bjp.0705909

10.1016/j.phrs.2003.07.001

10.1002/pmic.200401208

10.1161/hh0901.090440

10.1016/S0891-5849(02)01020-1

10.1016/j.freeradbiomed.2004.06.013

10.1038/sj.bjp.0705811

10.1146/annurev.cellbio.13.1.513

10.1006/abbi.1995.1321

10.1006/exnr.1997.6751

10.1046/j.1523-1755.2000.00046.x

10.1179/016164104225016236

10.1016/S0304-3940(99)00406-1

10.1002/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y

10.1097/00004647-199809000-00008

10.1038/jcbfm.1994.92

10.1016/j.cell.2005.05.016

10.1016/S0165-0173(99)00014-4

10.1038/sj.mp.4001240

10.1021/bi00126a001

10.1016/j.freeradbiomed.2003.07.004

10.1042/BJ20051277

10.1016/j.freeradbiomed.2005.03.014

10.1007/BF02293126

10.1021/ja00088a072

10.1161/01.CIR.82.4.1402

10.1152/ajpheart.00525.2003

10.1152/ajpheart.01080.2001

Tsuchihashi S, Kaldas F, Chida N, Sudo Y, Tamura K, Zhai Y, Qiao B, Busuttil RW, Kupiec-Weglinski JW.FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation.Am J Transplant.In press.

10.1067/msy.2000.104486

Turan N, Csonka C, Csont T, Giricz Z, Fodor G, Bencsik P, Gyongyosi M, Cakici I, Ferdinandy P.The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts.Cardiovasc Res.In press.

10.1074/jbc.M303734200

10.1152/ajpheart.2001.281.6.H2289

10.1124/pr.54.4.619

10.1023/B:DDAS.0000007874.20403.1d

Uchigata Y, Yamamoto H, Kawamura A, Okamoto H.Protection by superoxide dismutase, catalase, poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.J Biol Chem257: 6084–6088, 1982.

10.1016/S0002-9440(10)64166-1

10.1161/01.CIR.0000079165.84309.4D

10.1016/S0002-9440(10)63290-7

10.2174/1570161054368607

10.1152/ajpcell.00143.2003

10.1016/j.mam.2004.02.008

10.1146/annurev.biochem.72.121801.161647

10.1016/j.neuroscience.2004.12.038

10.1084/jem.192.12.1731

10.1016/S0165-5728(97)00013-1

10.1016/S0165-5728(98)00239-2

10.1074/jbc.272.12.7617

10.1164/ajrccm.160.1.9807044

10.1074/jbc.273.48.31860

10.1016/j.healun.2003.07.015

10.1097/00004872-199609002-00016

Varadarajan R, Golden-Mason L, Young L, McLoughlin P, Nolan N, McEntee G, Traynor O, Geoghegan J, Hegarty JE, O'Farrelly C.Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation.Transplantation78: 250–256, 2004.

10.1152/ajprenal.00427.2003

10.1111/j.1471-4159.2006.03742.x

Vargas MR, Pehar M, Cassina P, Estevez AG, Beckman JS, Barbeito L.Stimulation of nerve growth factor expression in astrocytes by peroxynitrite.In Vivo18: 269–274, 2004.

10.1046/j.1523-1755.1999.00670.x

10.1016/j.bbagen.2005.03.003

10.1161/hy0102.100540

10.1038/sj.onc.1204575

Viera L, Ye Y, Estévez A, Beckman J.Immunohistochemical methods to detect nitrotyrosine. In:Nitric Oxide: Biological and Antioxidant Activities, edited by Packer L. San Diego, CA: Academic, 1998, p. 373–381.

10.1073/pnas.91.26.12383

10.3109/10715769609088022

10.1021/bi9909445

10.2174/1570161054368625

10.1016/S0891-5849(00)00359-2

10.1124/pr.54.3.375

Virag L, Szabo E, Gergely P, Szabo C.Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.Toxicol Lett140–141: 113–124, 2003.

10.1161/01.HYP.0000034738.79310.06

10.1073/pnas.92.4.1137

10.1161/01.STR.28.11.2252

10.1016/j.niox.2004.04.006

10.1074/jbc.M310582200

10.1006/exnr.1996.6373

10.1007/s10495-006-7786-z

10.1161/hh0901.089987

10.1161/01.RES.0000217283.98806.a6

10.1074/jbc.271.46.29223

10.1016/S0008-6363(01)00445-X

10.1358/dnp.2000.13.3.657283

10.1097/00024382-199807000-00004

10.1016/S0924-977X(03)00065-8

10.1096/fasebj.14.2.271

10.1152/ajpgi.2001.281.2.G498

10.1016/S0891-5849(01)00706-7

10.1038/375408a0

10.1007/BF03401758

10.1084/jem.179.2.651

Weinstein DM, Mihm MJ, Bauer JA.Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice.J Pharmacol Exp Ther294: 396–401, 2000.

10.1161/01.RES.0000087542.26971.D4

10.1111/j.0105-2896.2005.00264.x

10.1074/jbc.M208572200

10.1097/00001756-200504250-00001

10.1097/00004647-199908000-00002

10.1089/10430340152710513

10.1136/hrt.2005.072280

10.1016/S0022-510X(00)00386-5

10.1073/pnas.91.3.1044

10.1042/bj3280517

10.1096/fj.03-1096fje

10.3109/10715769609149052

10.1136/ard.55.6.383

10.1016/0014-5793(95)01489-6

10.2337/diacare.27.5.1047

Wildhirt SM, Weis M, Schulze C, Conrad N, Pehlivanli S, Rieder G, Enders G, von Scheidt W, Reichart B.Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts.Circulation104SupplI: I-336–I-343, 2001.

10.1161/01.CIR.0000099580.72044.83

10.1016/j.freeradbiomed.2005.03.028

10.1016/j.niox.2005.01.003

10.1126/science.1948068

10.1021/tx00031a003

10.1016/0009-2509(68)89029-3

10.1161/01.ATV.20.6.1430

10.1161/01.HYP.0000165675.94771.38

10.3109/10739689609146778

10.1152/ajpcell.00456.2004

10.1111/j.1523-1755.2005.00257.x

10.1097/00041552-199901000-00015

10.1016/S0171-9335(98)80092-7

10.1016/0028-3908(94)90022-1

10.1152/japplphysiol.00461.2002

10.1016/0005-2795(68)90204-3

10.2337/diab.44.3.360

10.1152/ajpheart.1994.266.5.H2108

10.1074/jbc.274.36.25933

10.1046/j.1471-4159.2002.01106.x

10.1073/pnas.93.13.6770

10.1073/pnas.94.13.6954

10.1073/pnas.92.4.1242

10.1126/science.1373522

10.1161/01.RES.82.8.891

10.1152/ajpheart.01293.2005

10.1152/ajpheart.00037.2004

10.1074/jbc.M508135200

Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M.Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives.J Pharmacol Exp Ther298: 894–899, 2001.

Yamaguchi T, Yoshida N, Ichiishi E, Sugimoto N, Naito Y, Yoshikawa T.Differing effects of two nitric oxide synthase inhibitors on experimental colitis.Hepatogastroenterology48: 118–122, 2001.

Yamaguchi Y, Yoshikawa N, Kagota S, Nakamura K, Haginaka J, Kunitomo M.Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome.Nitric Oxide.In press.

10.1016/j.niox.2005.07.009

10.1093/jb/mvi095

10.1074/jbc.273.23.14085

10.1016/j.athoracsur.2003.12.025

10.1016/S0022-510X(97)00183-4

10.1152/ajpheart.01036.2004

10.1016/j.lfs.2003.09.076

10.1161/01.STR.25.1.165

10.1093/gerona/59.4.B316

10.1016/j.cccn.2005.06.002

10.1016/S0008-6363(96)00254-4

10.1016/S0076-6879(96)69022-3

10.1038/ncpcardio0346

10.1159/000064483

10.1211/0022357023024

10.1211/0022357022601

10.1016/S1089-8603(03)00025-9

10.1007/BF02973881

10.1038/jcbfm.1994.123

10.1021/tx050146h

10.1073/pnas.0501444102

10.1126/science.1072221

10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1

Yue G, Lai PS, Yin K, Sun FF, Nagele RG, Liu X, Linask KK, Wang C, Lin KT, Wong PY.Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production.J Pharmacol Exp Ther297: 915–925, 2001.

10.1097/00001756-200011090-00038

10.1021/ac50061a029

10.1159/000092197

10.1016/S0006-2952(99)00324-X

10.1152/ajpregu.1998.274.6.R1704

10.1038/jcbfm.1994.28

10.1016/j.pharmthera.2005.05.007

10.1074/jbc.M910425199

10.1093/jn/134.4.825

10.1046/j.1471-4159.2002.00975.x

10.1016/S0735-1097(01)01400-0

10.1016/S0300-9572(03)00240-5

10.1074/jbc.M510650200

10.1523/JNEUROSCI.2469-04.2004

10.1128/MCB.10.7.3818

10.1096/fj.05-5223com

10.1016/0006-8993(94)91574-1

10.1161/01.STR.24.12.2016

10.1097/00004647-199607000-00009

10.1073/pnas.0501719102

10.1016/j.jsgi.2004.05.003

10.1096/fj.05-5007com

10.1152/ajpheart.01064.2002

Zhou JL, Zhu XG, Ling YL, Li Q.Melatonin reduces peroxynitrite-induced injury in aortic smooth muscle cells.Acta Pharmacol25: 186–190, 2004.

10.1111/j.1471-4159.2004.02500.x

10.1111/j.1471-4159.2005.03639.x

10.1152/ajplung.2000.278.5.L1025

Zhu T, Ling Y, Zhao R.Role of peroxynitrite on airway hyperresponsiveness in asthmatic guinea-pigs.Zhonghua Jie He He Hu Xi Za Zhi23: 538–541, 2000.

10.1016/j.freeradbiomed.2005.05.001

Zingarelli B, Cuzzocrea S, Szabo C, Salzman AL.Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.J Pharmacol Exp Ther287: 1048–1055, 1998.

10.1038/sj.bjp.0700872

10.1111/j.1365-2567.2004.01991.x

10.1152/ajpheart.00953.2003

10.1016/S0014-2999(97)01325-3

10.1016/S0014-2999(03)01726-6

Zingarelli B, O'Connor M, Wong H, Salzman AL, Szabo C.Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide.J Immunol156: 350–358, 1996.

10.1097/00024382-199604000-00005

10.1136/gut.45.2.199

10.1161/hc4901.100379

10.1038/sj.bjp.0702434

10.1081/DMR-100101922

10.1084/jem.190.1.135

10.1080/10623320490482619

10.1074/jbc.M300215200

10.1074/jbc.M204512200

10.1016/S0002-9440(10)65390-4

10.2337/diabetes.51.1.198

10.1172/JCI0214442

10.1016/0014-5793(96)00160-3

Zouki C, Jozsef L, Ouellet S, Paquette Y, Filep JG.Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes.J Leukoc Biol69: 815–824, 2001.

10.1096/fj.00-0521fje

10.1089/152308601750100443